2026-03-20 20:34:58
EyePoint, Inc. Files Complaint Against Ocular Therapeutix for Defamation and Misleading Claims
Expected Stock impact: Noticeably Negative
On March 20, 2026, EyePoint, Inc. (the "Company") filed a complaint against Ocular Therapeutix, Inc. (the "Defendant") in the Middlesex County Superior Court for the Commonwealth of Massachusetts. The complaint alleges that the Defendant disseminated false or misleading representations regarding the Company and the clinical results of its lead product candidate, DURAVYU™ (vorolanib intravitreal insert). The Company asserts several causes of action against the Defendant, including defamation, commercial disparagement, violation of Massachusetts General Laws Chapter 93A, Sections 2 and 11, and tortious interference with advantageous business relations. EyePoint is seeking injunctive relief to prevent the Defendant from further disseminating these false representations, requiring a public retraction of the misleading statements, monetary damages, attorneys' fees, and any other relief deemed just and proper by the court. This legal action indicates a significant dispute that could impact the Company's reputation and market position, potentially leading to a noticeable negative effect on its stock price.
